Okyanos Heart Institute Hosts Upcoming June Seminars To Discuss Congestive Heart Failure
Free Educational Seminars Will Provide Insight About New Treatment Option Through Adult Stem Cell Therapy.
- (1888PressRelease) June 12, 2012 - FREEPORT, Bahamas - Okyanos Heart Institute (http://www.okyanos.com/), which brings a new standard of care and a better quality of life to patients with "no-option" coronary artery disease (CAD) via cardiac adult stem cell therapy, has announced that it will host a free educational seminar led by Chief Medical Officer Howard Walpole Jr., M.D., MBA, FACC, FACAI, FSCAI. In the seminar, Dr. Walpole will discuss the role of adult stem cell therapy and its potential benefits for people with CAD in danger of congestive heart failure. The seminar will take place on Wednesday, June 20 from 2 p.m. to 4 p.m. and Thursday, June 21 from 9 a.m. to 11 a.m. at The Waterfront Inn, located at 1105 Lake Shore Drive, The Villages, Fla. The seminars will be held again on Wednesday, June 27 from 2 p.m. to 4 p.m. and Thursday, June 28 from 9 a.m. to 11 a.m. at the Boca Raton Marriott, located at 5150 Town Center Circle, Boca Raton, Fla. Before and after each presentation, attendees will have the opportunity to meet individually with Walpole for a brief review of their own echocardiogram, EKG and nuclear scan reports to determine initial eligibility for cardiac adult stem cell therapy. Those who wish to learn about a new treatment option for patients who have previously had bypass surgery or stents, and who still experience symptoms associated with heart failure, such as shortness of breath and fatigue, are invited to attend. Complimentary hors d'oeuvres and beverages will be served.
Interested individuals can RSVP toll-free by phone at 1-855-659-6790 or online at http://okyanos.com/seminars. Seats are limited.
"Okyanos Heart Institute is pleased to offer free educational seminars on the benefits of adult stem cell therapy and the role this treatment option can play in the lives of individuals suffering from CAD," said Matthew Feshbach, co-founder and CEO of Okyanos Heart Institute. "Dr. Walpole will share valuable information about how Okyanos Heart Institute can help CAD patients find the treatment they need, and will be available for one-on-one meetings with attendees who wish to have this additional option. This is a perfect opportunity to have questions specific to your own medical history answered by a leading expert cardiologist."
"I look forward to the opportunity to provide insight into adult stem cell therapy for individuals suffering from this disease and to share the science behind this treatment for heart disease," said Walpole. "There are countless people that are facing the repercussions of coronary artery disease each day and are unaware of the newer treatment options that are available."
NEW MEDIA CONTENT:
Okyanos LinkedIn page:
Okyanos Facebook page:
Okyanos Twitter page:
ABOUT OKYANOS HEART INSTITUTE:
Based in Freeport, The Bahamas, the Okyanos Heart Institute is a Center of Excellence (CoE) adhering to U.S. surgical center standards and led by Chief Medical Officer Howard Walpole Jr., M.D., MBA, FACC, FACAI, FSCAI, a leader of the American College of Cardiology for many years. The mission of Okyanos Heart Institute is to bring a new standard of care and a better quality of life to patients with "no-option" coronary artery disease via cardiac adult stem cell therapy. The Greek god of rivers, "Okyanos" symbolizes the primary mechanism of action that these adult stem cells have on ischemic (lack of blood flow) heart tissue, the result of the plaque deposits in the coronary arteries. The stem cells, derived from a person's adipose (fat) tissue, create new blood vessels, a process known as angiogenesis. These cells facilitate blood flow in the heart and intake and use of oxygen, as measured by a rigorous clinical trial known as the PRECISE trial, as well as cardiac cell therapy trials at leading research institutions. For more information, visit http://www.okyanos.com/.
MMI Public Relations
anjelica ( @ ) mmipublicrelations dot com